1. Home
  2. CLDI vs CVV Comparison

CLDI vs CVV Comparison

Compare CLDI & CVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDI
  • CVV
  • Stock Information
  • Founded
  • CLDI 2014
  • CVV 1982
  • Country
  • CLDI United States
  • CVV United States
  • Employees
  • CLDI N/A
  • CVV N/A
  • Industry
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • CVV Industrial Machinery/Components
  • Sector
  • CLDI Health Care
  • CVV Technology
  • Exchange
  • CLDI Nasdaq
  • CVV Nasdaq
  • Market Cap
  • CLDI 20.2M
  • CVV 20.5M
  • IPO Year
  • CLDI N/A
  • CVV N/A
  • Fundamental
  • Price
  • CLDI $0.59
  • CVV $3.67
  • Analyst Decision
  • CLDI
  • CVV
  • Analyst Count
  • CLDI 0
  • CVV 0
  • Target Price
  • CLDI N/A
  • CVV N/A
  • AVG Volume (30 Days)
  • CLDI 51.3M
  • CVV 33.2K
  • Earning Date
  • CLDI 08-12-2025
  • CVV 08-12-2025
  • Dividend Yield
  • CLDI N/A
  • CVV N/A
  • EPS Growth
  • CLDI N/A
  • CVV N/A
  • EPS
  • CLDI N/A
  • CVV N/A
  • Revenue
  • CLDI N/A
  • CVV $30,270,000.00
  • Revenue This Year
  • CLDI N/A
  • CVV N/A
  • Revenue Next Year
  • CLDI N/A
  • CVV N/A
  • P/E Ratio
  • CLDI N/A
  • CVV N/A
  • Revenue Growth
  • CLDI N/A
  • CVV 48.85
  • 52 Week Low
  • CLDI $0.20
  • CVV $2.46
  • 52 Week High
  • CLDI $3.89
  • CVV $4.80
  • Technical
  • Relative Strength Index (RSI)
  • CLDI 51.83
  • CVV 54.66
  • Support Level
  • CLDI $0.56
  • CVV $3.40
  • Resistance Level
  • CLDI $0.91
  • CVV $3.75
  • Average True Range (ATR)
  • CLDI 0.10
  • CVV 0.23
  • MACD
  • CLDI -0.02
  • CVV 0.01
  • Stochastic Oscillator
  • CLDI 27.34
  • CVV 55.96

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

About CVV CVD Equipment Corporation

CVD Equipment Corp is engaged in the manufacturing of chemical vapor deposition equipment, customized gas control systems, the manufacturing of process equipment suitable for the synthesis of a variety of one-dimensional nanostructures and nanomaterials and a line of furnaces, all of which are used to produce semiconductors and other electronic components. The company operates through the segments of CVD Equipment, CVD materials, and Stainless Design Concepts, MesoScribe. It generates maximum revenue from the CVD Equipment segment. The CVD Equipment segment manufactures and sells chemical vapor deposition, physical vapor transport, and similar equipment. Company operates in USA, North America, Europe, Middle East and Africa, and Asia-Pacific.

Share on Social Networks: